Military-related factors affecting survival of veterans with motor neuron disease

July 11, 2018 by Beth Jones, Public Library of Science
Military-related factors affecting survival of veterans with motor neuron diseas
Credit: PLOS Blogs

Military veterans may have higher rates of death from the progressive neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, than non-veterans. However, few studies have examined what might be behind this association. The authors of a PLOS ONE study evaluated the relationship between various military-related factors and ALS survival among U.S. veterans.

The study has just been awarded the 2018 PLOS Veterans Disability & Rehabilitation Research Channel Prize. I interviewed via email co-author John Beard, epidemiologist and Assistant Professor in the Department of Public Health at Brigham Young University, to find out more.

What drew you to study epidemiology?

JB: It happened gradually over time. I've been interested in numbers and research since I was about 10 years old, so I majored in statistics for my undergraduate degree. I then earned graduate degrees in public health and epidemiology so that I could apply statistics to real problems that affected real people. I had some great mentors in graduate school and during internships who helped me to discover that epidemiology was enjoyable, fulfilling, and a good fit for me.

In your study, you examined rates of amyotrophic lateral sclerosis (ALS) mortality amongst US military veterans. Why did you decide to study this topic?

JB: About half of ALS patients die within 2-3 years of , but about 4 percent survive more than 10 years. Aside from certain clinical characteristics, we don't really know why the survival of ALS patients is so variable. In addition, there is emerging evidence that the probability of developing ALS is higher among military veterans than non-veterans, but only four previous studies had considered whether military-related characteristics might be associated with survival after ALS diagnosis. We hoped that identifying subsets of military veterans who had worse survival after ALS diagnosis might help clinicians target treatments or interventions.

What did you find?

JB: We found that survival after ALS diagnosis was on average relatively short among those veteran ALS patients who served in the military before 1950, were deployed to World War II, or mixed and applied burning agents. In contrast, veteran ALS patients who were exposed to paint, solvents, or petrochemical substances, local food not provided by the Armed Forces, or burning agents or Agent Orange in the field, survived on average longer than veteran ALS patients who were not exposed to these. It's important to point out that our study was the first to consider many of these military-related characteristics in association with survival after ALS diagnosis, so our results need to be confirmed by additional studies in other military and non-military populations.

What most interested you in your findings, and why?

JB: I was most interested in the findings that being deployed to World War II and having mixed and applied burning agents were associated with shorter survival of veteran ALS patients, because we found in another recent study that these same military characteristics were also associated with veterans having an increased probability of developing ALS in the first place. Thus, certain characteristics might lead both to developing ALS and to shorter survival after ALS diagnosis. Body mass index (BMI) may be a non-military example: there is emerging evidence that people with a lower BMI may be more likely to develop ALS than people with a higher BMI, and ALS patients with a lower BMI may also have shorter survival after diagnosis than ALS patients with a higher BMI.

What do you hope your research might lead to?

JB: I hope our research leads to more studies of associations between clinical or non-clinical characteristics and survival after ALS diagnosis. This could help to identify ALS who are more likely to have shorter survival, so they can receive treatments or interventions that might lengthen their lives.

You have just been awarded the 2018 PLOS Veterans Disability & Rehabilitation Research Channel Prize for this work. How did you feel when you found out that you'd won?

JB: I was pleasantly surprised that our paper was nominated for the award and that it won. ALS is thankfully a rare disease and the ALS research and patient communities are relatively small, so I was pleased that people outside of those communities were interested in how military-related characteristics might be associated with survival after ALS diagnosis.

What do you plan to do with your $500 prize money?

JB: I'll share it with my co-authors, but we haven't yet discussed plans.

Explore further: Skin cancer risk higher in military personnel

More information: John D. Beard et al. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival, PLOS ONE (2017). DOI: 10.1371/journal.pone.0185751 John D. Beard et al. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival, PLOS ONE (2017). DOI: 10.1371/journal.pone.0185751

Related Stories

Skin cancer risk higher in military personnel

July 8, 2018
(HealthDay)—There is an increased risk for skin cancer among U.S. active duty service members and veterans, according to a review published in the June issue of the Journal of the American Academy of Dermatology.

Suicide in veterans – study finds mixed picture

May 12, 2017
People who have served in the armed forces do not have a greater risk of suicide overall than people who have never served in the military, but there is an increased risk in certain groups, according to a study by the University ...

Tobacco's grip on U.S. veterans

January 12, 2018
(HealthDay)—Nearly 40 percent of U.S. military veterans smoke or use some form of tobacco.

Mind-body therapy effective for military veterans with PTSD

February 9, 2018
Post-9/11 military veterans who receive mind-body therapy have significant improvements in symptoms of post-traumatic stress disorder (PTSD), according to a study co-authored by University of Hawaiʻi at Mānoa Professor ...

Veterans not at higher risk of leukaemia, finds study

March 2, 2017
People who have served in the Armed Forces do not have an increased risk of leukaemia or other blood cancers, according to a study by the University of Glasgow.

Recommended for you

Scientists uncover the role of a protein in production and survival of myelin-forming cells

July 19, 2018
The nervous system is a complex organ that relies on a variety of biological players to ensure daily function of the human body. Myelin—a membrane produced by specialized glial cells—plays a critical role in protecting ...

Neurons can carry more than one signal at a time

July 18, 2018
Back in the early days of telecommunications, engineers devised a clever way to send multiple telephone calls through a single wire at the same time. Called time-division multiplexing, this technique rapidly switches between ...

Researchers solve mystery of how ALL enters the central nervous system

July 18, 2018
A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system.

Pregnancy history may be tied to Alzheimer's disease

July 18, 2018
A woman's history of pregnancy may affect her risk of Alzheimer's disease decades later, according to a study published in the July 18, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. ...

Forty percent of people have a fictional first memory, says study

July 17, 2018
Researchers have conducted one of the largest surveys of people's first memories, finding that nearly 40 per cent of people had a first memory which is fictional.

Protein found to be key component in irregularly excited brain cells

July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.